Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Surgical Oncology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
Pacak K, Tella SH. Pheochromocytoma and Paraganglioma. In: Feingold KR, Anawalt B, Boyce A, et al., eds. Endotext. South Dartmouth (MA): MDText.com, Inc.Copyright © 2000-2022; 2000.
- AJCC cancer staging manual.Springer, New York, NY2016
- An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma.Best Pract Res Clin Endocrinol Metab. 2020; 34: 101416
- Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.J Clin Endocrinol Metab. 2014; 99: 1915-1942
- Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.Cancer Cell. 2017; 31: 181-193
- Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase.Cancer Cell. 2005; 7: 77-85
- Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas.Hum Mol Genet. 2014; 23: 2440-2446
- Whole-Exome Sequencing Identifies MDH2 as a New Familial Paraganglioma Gene.JNCI: J Natl Cancer Inst. 2015; 107
- Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia.N Engl J Med. 2012; 367: 922-930
- Germline mutations in TMEM127 confer susceptibility to pheochromocytoma.Nat Genet. 2010; 42: 229-233
- Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma.Nat Genet. 2011; 43: 663-667
- Genetic testing in pheochromocytoma or functional paraganglioma.J Clin Oncol. 2005; 23: 8812-8818
- Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas.J Clin Endocrinol Metab. 2007; 92: 3822-3828
- Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.Cancer Res. 2003; 63: 5615-5621
- 15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1-5.Endocr Relat Cancer. 2015; 22: T91-T103
- Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.J Clin Endocrinol Metab. 2006; 91: 827-836
- Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.Jama. 2004; 292: 943-951
- Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.Jama. 2005; 294: 2057-2063
- SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma.Clin Cancer Res. 2011; 17: 247-254
- High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas: implications for genetic testing.J Clin Endocrinol Metab. 2006; 91: 4505-4509
- Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD.Hum Mutat. 2010; 31: 41-51
- Frequent incidental discovery of phaeochromocytoma: data from a German cohort of 201 phaeochromocytoma.Eur J Endocrinol. 2009; 161: 355-361
- Loss of SDHA expression identifies SDHA mutations in succinate dehydrogenase-deficient gastrointestinal stromal tumors.Am J Surg Pathol. 2013; 37: 226-233
- Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma.The J Clin Endocrinol Metab. 2019; 104: 1109-1118
- Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas.Nat Rev Endocrinol. 2017; 13: 233-247
- Cost-minimization analysis of sequential genetic testing versus targeted next-generation sequencing gene panels in patients with pheochromocytoma and paraganglioma.Ann Med. 2021; 53: 1243-1255
- SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T).Mod Pathol. 2015; 28: 807-821
- An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.Lancet Oncol. 2009; 10: 764-771
- Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.Hum Pathol. 2010; 41: 805-814
- Superiority of [68Ga]-DOTATATE PET/CT to Other Functional Imaging Modalities in the Localization of SDHB-Associated Metastatic Pheochromocytoma and Paraganglioma.Clin Cancer Res : official J Am Assoc Cancer Res. 2015; 21: 3888-3895
- Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.J Natl Cancer Inst. 2012; 104: 700-708
- Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma.J Clin Oncol. 2007; 25: 2262-2269
- 123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation.Clin Endocrinol (Oxf). 2008; 69: 181-188
- Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial.J Nucl Med. 2009; 50: 1448-1454
- Efficacy and Safety of High-Specific-Activity (131)I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma.J Nucl Med. 2019; 60: 623-630
- Hemodynamic Stability During Pheochromocytoma Resection: Lessons Learned Over the Last Two Decades.Ann Surg Oncol. 2015; 22: 4175-4180
- Efficacy of alpha-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial.J Clin Endocrinol Metab. 2020; 105
- Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma.World J Surg. 2002; 26: 1037-1042
- The use of doxazosin before adrenalectomy for pheochromocytoma: is the duration related to intraoperative hemodynamics and postoperative complications?.Int Urol Nephrol. 2020; 52: 2079-2085
- Pheochromocytoma surgery without systematic preoperative pharmacological preparation: insights from a referral tertiary center experience.Surg Endosc. 2021; 35: 728-735
- International multicentre review of perioperative management and outcome for catecholamine-producing tumours.Br J Surg. 2020; 107: e170-e178
- Propranolol-induced pulmonary edema and shock in a patient with pheochromocytoma.Arch Intern Med. 1984; 144: 173-174
- alpha-Methyl-p-tyrosine: a review of its pharmacology and clinical use.Drugs. 1981; 21: 81-89
- Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma.Curr Oncol Rep. 2013; 15: 356-371
- Surgical Treatment of Malignant Pheochromocytoma and Paraganglioma: Retrospective Case Series.Ann Surg Oncol. 2017; 24: 1546-1550
- Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators.J Clin Endocrinol Metab. 2011; 96: 717-725
- Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic Paraganglioma.Ann Surg. 2018; 268: 172-178
- Malignant pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades.J Surg Oncol. 2013; 107: 659-664
- Outcomes of resection of extra-adrenal pheochromocytomas/paragangliomas in the laparoscopic era: a comparison with adrenal pheochromocytoma.Surg Endosc. 2013; 27: 428-433
- Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery.Surgery. 2018; 163: 191-196
- SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma.Surgery. 2017; 161: 230-239
- Impact of surgical resection for subdiaphragmatic paragangliomas.World J Surg. 2014; 38: 733-741
- En Bloc Resection with Major Blood Vessel Reconstruction for Locally Invasive Retroperitoneal Paragangliomas: A 15-Year Experience with Literature Review.World J Surg. 2017; 41: 997-1004
- Surgical management of hereditary pheochromocytoma.J Am Coll Surg. 2004; 198 ([discussion: 534-525]): 525-534
- Long-term outcomes of surgical treatment for hereditary pheochromocytoma.J Am Coll Surg. 2013; 216: 280-289
- Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study.The Lancet Oncol. 2014; 15: 648-655
- Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing Adrenalectomy.JAMA Netw Open. 2019; 2: e198898
- AJCC cancer staging manual.8th edition. Springer International Publishing: American Joint Commission on Cancer, 2017
- Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years.J Clin Endocrinol Metab. 2017; 102: 3296-3305
- Response after surgical resection of metastatic pheochromocytoma and paraganglioma: can postoperative biochemical remission be predicted?.J Am Coll Surg. 2013; 217: 489-496
- MANAGEMENT OF ENDOCRINE DISEASE: Outcome of adrenal sparing surgery in heritable pheochromocytoma.Eur J Endocrinol. 2016; 174: R9-R18
- Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.J Clin Endocrinol Metab. 2014; 99: 1915-1942
- European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma.Eur J Endocrinol. 2016; 174: G1-G10
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
